Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?
- PMID: 11207224
- PMCID: PMC1721217
- DOI: 10.1136/fn.84.2.f96
Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?
Abstract
Objective: To examine the number and volume of red blood cell transfusions (RBCTs) in very and extremely low birthweight infants under restrictive red blood cell transfusion guidelines without erythropoietin administration, and to compare the results with those reported in similar infants receiving erythropoietin.
Methods: From April 1996 to June 1999, all RBCTs given to infants with a birth weight of less than 1500 g were prospectively recorded. Data on RBCT combined with erythropoietin treatment and RBCT guidelines were extracted from four prospective randomised trials of erythropoietin for anaemia of prematurity.
Results: When the restrictive RBCT guidelines were followed, the number of RBCTs and volume transfused were similar to those reported during erythropoietin administration.
Conclusions: RBCT guidelines may have a similar impact on RBCT in very low birthweight infants to the administration of erythropoietin. The effect of RBCT guidelines on RBCT frequency should be considered when evaluating the efficacy of erythropoietin administration to preterm infants.
Similar articles
-
Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.Saudi Med J. 2006 Jun;27(6):817-20. Saudi Med J. 2006. PMID: 16758042 Clinical Trial.
-
Red Blood Cell Transfusion in Preterm Infants: Current Evidence and Controversies.Neonatology. 2018;114(1):7-16. doi: 10.1159/000486584. Epub 2018 Mar 16. Neonatology. 2018. PMID: 29550819 Review.
-
[Recombinant human erythropoietin: analysis of a policy of treatment in an hospital based population of very-low-birthweight infants].Arch Pediatr. 2003 Jun;10(6):499-505. doi: 10.1016/s0929-693x(03)00147-7. Arch Pediatr. 2003. PMID: 12915011 French.
-
Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g.J Pediatr. 2000 Feb;136(2):220-4. doi: 10.1016/s0022-3476(00)70105-3. J Pediatr. 2000. PMID: 10657829 Clinical Trial.
-
Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.Paediatr Drugs. 2002;4(2):111-21. doi: 10.2165/00128072-200204020-00004. Paediatr Drugs. 2002. PMID: 11888358 Review.
Cited by
-
Patterns of phlebotomy blood loss and transfusions in extremely low birth weight infants.J Perinatol. 2019 Dec;39(12):1670-1675. doi: 10.1038/s41372-019-0515-6. Epub 2019 Oct 3. J Perinatol. 2019. PMID: 31582812 Free PMC article.
-
Recombinant erythropoietin in clinical practice.Postgrad Med J. 2003 Jul;79(933):367-76. doi: 10.1136/pmj.79.933.367. Postgrad Med J. 2003. PMID: 12897214 Free PMC article. Review.
-
High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.J Pediatr. 2020 Jul;222:98-105.e3. doi: 10.1016/j.jpeds.2020.03.055. Epub 2020 May 14. J Pediatr. 2020. PMID: 32418819 Free PMC article.
-
Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion.Child Neuropsychol. 2011;17(4):347-67. doi: 10.1080/09297049.2010.544647. Child Neuropsychol. 2011. PMID: 21360360 Free PMC article. Clinical Trial.
-
A Mechanism-Based Population Pharmacokinetics Model of Erythropoietin in Premature Infants and Healthy Adults Following Multiple Intravenous Doses.J Clin Pharmacol. 2019 Jun;59(6):835-846. doi: 10.1002/jcph.1368. Epub 2019 Jan 7. J Clin Pharmacol. 2019. PMID: 30618050 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous